COVID vaccine boosters are proving a useful tool against Omicron, but scientists say that endless boosting might not be a practical or sustainable strategy.
. This more durable immunity “also wanes, but to a lesser extent”, says Balicer, meaning that a third shot might be enough to prevent people getting critically ill.
“Hopefully, this third shot is enough” for most people to prevent severe disease and offer some protection against infection, Balazs adds. But The first data on Omicron-specific vaccines are expected within months — although even that might be too late given how quickly the variant spreads. A pan-coronavirus vaccine that covers all strains as well as related viruses would be preferable, but “whether this will be possible isn’t yet clear,” says disease ecologist Marm Kilpatrick at the University of California Santa Cruz. “There is always substantial uncertainty when dealing with viral evolution.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Moderna begins testing omicron-matched COVID shots in adultsThe company announced Wednesday that the first participant had received a dose. Earlier this week, competitor Pfizer began a similar study of its own reformulated shots.
Baca lebih lajut »
Moderna begins testing omicron-matched COVID shots in adultsThe company announced Wednesday that the first participant had received a dose. Earlier this week, competitor Pfizer began a similar study of its own reformulated shots.
Baca lebih lajut »
As omicron rages, Utah lawmakers go after local COVID restrictionsUtah lawmakers during week one of the 2022 legislative session passed a joint resolution, abolishing local mask mandates ordered by city and county leaders throughout the state.
Baca lebih lajut »
What to know about BA.2, the newest Covid omicron variantAs coronavirus case numbers in the U.S. show early signs of tapering, scientists are keeping a watchful eye on a newly identified version of the omicron
Baca lebih lajut »
Moderna starts clinical trial of booster shot targeting omicron Covid variantThe first participant in the trial has already received a dose of the omicron-specific booster shot, according to Moderna.
Baca lebih lajut »